1
Baricitinib Therapy in COVID-19
Condition(s):COVID; PneumoniaLast Updated:April 24, 2020Completed
Baricitinib: 89 Clinical Trials, Page 1 of 9
Hide Studies Not Open or Pending
2
Baricitinib for the Prophylaxis of Graft-Versus-Host Disease After Peripheral Blood Hematopoietic Cell Transplantation
Condition(s):Graft-versus-host-disease; Graft Vs Host DiseaseLast Updated:March 23, 2021Recruiting
3
Baricitinib for coRona Virus pnEumonia (COVID-19): a THerapeutic Trial
Condition(s):Corona Virus InfectionLast Updated:May 22, 2020Not yet recruiting
4
A Study of Baricitinib (LY3009104) in Adult and Pediatric Japanese Participants With NNS/CANDLE, SAVI, and AGS
Condition(s):Nakajo-Nishimura Syndrome; Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature Syndrome; STING-Associated Vasculopathy With Onset in Infancy; Aicardi Goutieres SyndromeLast Updated:December 19, 2020Recruiting
5
A Study of Baricitinib in Healthy Participants
Condition(s):HealthyLast Updated:March 26, 2019Completed
6
Safety and Efficacy of Baricitinib for COVID-19
Condition(s):COVID-19Last Updated:March 8, 2021Withdrawn
7
A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
Condition(s):Juvenile Idiopathic ArthritisLast Updated:April 8, 2021Recruiting
8
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Condition(s):Atopic DermatitisLast Updated:March 19, 2021Recruiting
9
A Study to Measure Baricitinib (LY3009104) Absorption in Healthy Participants
Condition(s):Healthy VolunteersLast Updated:June 1, 2017Completed
10
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)
Condition(s):Systemic Lupus ErythematosusLast Updated:April 8, 2021Recruiting